Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 4, 2007, Pages 321-326

  Marcucci, Rossella ^a   Sodi, Andrea ^a   Giambene, Barbara ^a   Liotta, Agatina Alessandrello ^a   Poli, Daniela ^a   Mannini, Lucia ^a   Falciani, Michela ^a   Abbate, Rosanna ^a   Menchini, Ugo ^a   Prisco, Domenico ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiovascular risk factors; Genetic polymorphisms; Homocysteine; Lipoprotein(a); Retinal artery occlusion; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; CHOLESTEROL; LIPOPROTEIN A; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INDEPENDENT VARIABLE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPHTHALMOLOGY; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RISK FACTOR; THROMBOPHILIA; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN(A); MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL ARTERY OCCLUSION; RISK FACTORS; SMOKING; THROMBOPHILIA;

EID: 34247844447     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32809cc922     Document Type: Article

References (49)

1. Mangat HS. Retinal artery occlusion. Surv Ophthalmol 1995; 40:145-156.
2. Brown GC. Arterial obstruction disease and the eye. Int Ophthalmol Clin North Am 1990; 3:373-392.
3. Greven CM. Retinal arterial occlusions in the young. Curr Opin Opthalmol 1997; 8:3-7.
4. Sharma S. The systemic evaluation of acute retinal artery occlusion. Curr Opin Opthalmol 1998; 9:1-5.
5. Graham EM. The investigation of patients with retinal vascular occlusion. Eye 1990; 4:464-468.
6. Agarwal S, Shanmugam MP, Gopal L, Krishnakumar S, Biswas J. Necrotic melanocytoma of the optic disk with central retinal vascular obstruction. Retina 2005; 25:364-367.
7. Chan WM, Liu DT, Lam DS. Images in haematology. Combine central retinal artery and vein occlusions as the presenting signs of ocular relapse in acute lymphoblastic leukaemia [letter]. Br J Hematol 2005; 128:134.
8. Valverde K, Pandya J, Heon E, Goh TS, Gallie BL, Chan HS. Retinoblastoma with central retinal artery thrombosis that mimics extraocular disease. Med Pediatr Oncol 2002; 38:277-279.
9. Shields JA, Shields CL, Eagle RC Jr, Singh AD, Berrocal MH, Berrocal JA. Central retinal vascular obstruction secondary to melanocytoma of the optic disc. Arch Ophthalmol 2001; 119:129-133.
10. Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with huma immunodeficiency virus. Retina 2005; 25:759-766.
11. Wong DM, Ilsen PF, Bright DC, Anderson SF, Townsend JC. Case presentations of retinal artery occlusions. Optometry 2000; 71:703-714.
12. Blaise P, Duchateau E, Duchesne B, Conhaire Y, Rakic JM. Retinal vascular occlusions: diagnosis and management. Rev Med Interne 2004; 25:881-890.
13. Cahill MT, Fekrat S. Arteriovenous sheathotomy for branch retinal vein occlusion. Ophthalmol Clin North Am 2002; 15:417-423.
14. Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 2002; 12:495-500.
15. Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, et al. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol 2002; 134:57-61.
16. Salomon O, Huna-Baron R, Moissiev J, Rosenberg N, Rubovitz A, Steinberg DM, et al. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye 2001; 15:511-514.
17. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion and central retinal vein occlusion. Ophthalmology 2000; 107:1588-1592.
18. Cahill M, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12 and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003; 136:1136-1150.
19. Van Cott EM, Laposata M, Hartnett ME. Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis 2004; 15:393-397.
20. Talmon T, Scharf J, Mayer E, Lanir N, Miller B, Brenner B. Retinal artery occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. Am J Ophthalmol 1997; 124:689-691.
21. Weger M, Renner W, Pinter O, Stanger O, Temmel W, Fellner P, et al. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion. Eye 2003; 17:731-734.
22. Ben-Ami R, Zeltser D, Leibowitz I, Berliner SA. Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations. Blood Coagul Fibrinolysis 2002; 13:57-59.
23. Larsson J. Central retinal artery occlusion in a patient homozygous for factor V Leiden. Am J Ophthalmol 2000; 129:816-817.
24. Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999; 23:155-160.
25. Tavola A, D'Angelo SV, Bandello F. Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein(a) levels: a case report. Thromb Res 1995; 80:327-331.
26. Murata M, Saito T, Takahashi S, Ichinose A. Plasma lipoprotein (a) levels are high in patients with central artery occlusion. Thromb Res 1998; 91:169-175.
27. Muller HM, Diekstall FF, Schmidt E, Marz W, Canzler H, Demeler U. Lipoprotein (a): a risk factor for retinal vascular occlusion. Ger J Ophthalmol 1992; 1:338-341.
28. Vielpeau I, Le Hello C, Legris A, Salsou E, Lecoq PJ, Retinal vascular occlusion and primary antiphospholipid syndrome. Report of 2 cases. J Fr Ophthalmol 2001; 24:955-960.
29. Chobainian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JRJL, et al. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2571.
30. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
31. Reports of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26:S5-S20.
32. Stein JH, Rosenson RS. Lp(a) excess and coronary heart disease. Arch Intern Med 1997; 157:1170-1176.
33. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998; 19:A53-A61.
34. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R. Stroke prevention: management of modifiable vascular risk factors. J Neurol 2002; 249:507-517.
35. Kim CK, Schmalfuss CM, Schofield RS, Sheps DS. Pharmacological treatment of patients with peripheral arterial disease. Drugs 2003; 63:637-647.
36. Handy DE, Loscalzo J. Homocysteine and atherothrombosis: diagnosis and treatment. Curr Atheroscler Rep 2003; 5:276-283.
37. Peterson JC, Spence JD. Vitamins and progression of atherosclerosis in hyper-homocysteinemia [letter]. Lancet 1998; 351:263.
38. Marcucci R, Zanazzi M, Bertoni E, Fedi S, Lenti M, Prisco D, et al. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients. Transplantation 2003; 75:1551-1555.
39. Till U, Rohl P, Jentsch A, Till H, Muller A, Bellstedt K, et al. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis 2005; 181:131-135.
40. Schnyder G, Flammer Y, Roffi M, Pin R, Hess OM. Plasma honocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol 2002; 40:1769-1776.
41. Lange H, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004; 350:2673-2681.
42. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291:565-575.
43. Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Wouter Jukema J, van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. JAMA 2003; 41:2105-2113.
44. Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci U S A 2003; 100:15089-15094.
45. Lippi G, Guidi G. Lipoprotein (a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003; 40:1-42.
46. Martinelli I. von Willebrand factor and FVIII as risk factors for arterial and venous thrombosis. Semin Hematol 2005; 42:49-55.
47. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000; 84:914-916.
48. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye 2005; 24:493-519.
49. Akaike M, Azuma H, Kagawa A, Matsumoto K, Hayashi I, Tamura E, et al. Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem 2002; 48:1454-1459.